Post Authorization Safety Profile of Booster IndoVac COVID-19 Vaccination
NCT06690502 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1208
Last updated 2024-11-15
Summary
This study is Post Authorization Safety Study (PASS) Phase IV of Booster IndoVac COVID-19 Vaccination
Conditions
Sponsors & Collaborators
-
PT Bio Farma
lead INDUSTRY
Principal Investigators
-
Hindra Irawan Satari, Prof., Dr., dr., SpA(K), M. Trop. Paed · National Committee of Adverse Events Following Immunization / NC Indonesia
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-12-18
- Primary Completion
- 2024-06-03
- Completion
- 2024-06-07
Countries
- Indonesia
Study Locations
More Related Trials
-
Safety Evaluation of a Q-fever Vaccine, NDBR 105
NCT00584454 ·Status: COMPLETED ·Phase: PHASE2
-
INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years Old
NCT06282692 ·Status: RECRUITING ·Phase: PHASE3
-
BBV152/BBV154 Heterologus Prime-Boost Study
NCT05639998 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Booster Study in Healthy Adults in Australia
NCT05658523 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Randomized Trial of COVID-19 Booster Vaccinations (Cobovax Study)
NCT05057169 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of Q Fever Vaccine
NCT02092142 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study on Booster Immunization With Varicella Vaccine at Different Intervals
NCT06994052 ·Status: COMPLETED ·Phase: PHASE4
-
Phase III Study of BBV154 Intranasal Vaccine in Healthy Volunteers
NCT05522335 ·Status: UNKNOWN ·Phase: PHASE3
-
COVID-19 Vaccines Safety Tracking (CoVaST)
NCT04834869 ·Status: RECRUITING
-
A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19
NCT04756830 ·Status: UNKNOWN ·Phase: PHASE4
-
Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine
NCT04930003 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals
NCT04456595 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age.
NCT02459262 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Reactogenicity and Immunogenicity of a Novel MVA-SARS-2-ST Vaccine Candidate
NCT05226390 ·Status: TERMINATED ·Phase: PHASE1
-
Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly
NCT05283902 ·Status: COMPLETED
-
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults
NCT01160172 ·Status: COMPLETED ·Phase: PHASE1
-
Booster Study of PTX-COVID19-B in Adults Aged 18 Years and Older
NCT05534048 ·Status: UNKNOWN ·Phase: PHASE3
-
A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older
NCT05603052 ·Status: COMPLETED ·Phase: PHASE3
-
ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020)
NCT00550745 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Safety and Satisfaction Toward COVID-19 Vaccines.
NCT05857176 ·Status: COMPLETED
-
EU Secondary Data Post-Authorisation Safety Study of AZD1222
NCT05126992 ·Status: COMPLETED
-
Local and General Immune Response After Coronavirus Disease (COVID-19) Vaccination in Volunteers
NCT04996238 ·Status: COMPLETED ·Phase: NA
-
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
NCT07300839 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Booster Vaccination Against COVID-19
NCT04979949 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029)
NCT01245751 ·Status: COMPLETED ·Phase: PHASE3